| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4249123 | Revista Española de Medicina Nuclear | 2009 | 4 Pages |
Abstract
Our results suggest that: a) the expression of COX-2 > ++ is often found in this kind of lung cancer and is not associated with the clinical stage; b) the maxSUVs were not related to the stage and were lower in COX-2 > ++ tumours than in the other cases; and c) the different behaviour of both parameters can be explained by their correlation with cell proliferation (MIB1), EGFR and p16 expression.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
A. Ruibal, I. Abdulkader, F. Gude, M. Pombo, L. León, J. Barandela, A. Sánchez-Salmón,